Are antihypertensive drugs associated with abdominal aortic aneurysms?

OBJECTIVE The aim of this study was to investigate the association between anti-hypertensive drugs, the risk of developing an abdominal aortic aneurysm (AAA), aortic wall stiffness, collagen turnover, and change in aortic diameter. STUDY DESIGN, SETTINGS AND METHODS: Data on present medication, smoking status, and medical history of participants in two population-based aneurysm screening programs in the United Kingdom were collected by use of questionnaire. Aortic elasticity was measured by M-mode ultrasound scanning. A serum radioimmunoassay of the amino-terminal propeptide of type III procollagen was used to assess collagen turnover in one of the patient series. RESULTS Data from 438 cases with an AAA >29 mm and 5373 controls were analyzed. Calcium-channel blockers were independently associated with AAA. The odds ratio of having an AAA was 2.6 (95% confidence interval [CI], 1.5-4.2) after adjusting for all relevant confounders. Other antihypertensive drugs showed no increased risk. No significant differences in growth rates were found in cases exposed to any of the main antihypertensive drugs. An increased collagen turnover was found in subjects receiving angiotensin-converting enzyme (ACE) inhibitors: 4.26 mg/L (95% CI, 3.73-4.79) compared with 3.62 mg/L (95% CI, 3.49-3.76) for subjects not receiving ACE inhibitors. No differences in type III collagen turnover was found with use of any other antihypertensive drug. The mean aortic wall stiffness was greater for all subjects exposed to calcium-channel blockers, whether with AAA or not: 25.1 arbitrary units (95% CI, 20.0-30.2) vs 19.3 (95% CI, 18.1-20.4)(P =.002). By contrast, the mean stiffness for cases receiving ACE inhibitors was smaller than for those not receiving ACE inhibitors: 19.0 (95% CI, 13.9-24.0) vs 25.2 (95% CI, 23.0-27.4). CONCLUSIONS Calcium-channel blockers were an independent risk factor for the presence of an AAA and were associated with an increased arterial aortic wall stiffness. ACE inhibitors were associated with decreased stiffness and greater collagen turnover. No significant effects on the growth rate of small aneurysms were detected.

[1]  Jeroen J. Bax,et al.  Bisoprolol reduces cardiac death and myocardial infarction in high-risk patients as long as 2 years after successful major vascular surgery. , 2001, European heart journal.

[2]  Jeroen J. Bax,et al.  The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. , 1999, The New England journal of medicine.

[3]  T. Prevost,et al.  Growth rates and risk of rupture of abdominal aortic aneurysms , 1998, The British journal of surgery.

[4]  L. Golub,et al.  Pharmacologic suppression of experimental abdominal aortic aneurysms: acomparison of doxycycline and four chemically modified tetracyclines. , 1998, Journal of vascular surgery.

[5]  Mark D. Huffman,et al.  Expression and localization of macrophage elastase (matrix metalloproteinase-12) in abdominal aortic aneurysms. , 1998, The Journal of clinical investigation.

[6]  P. Bell,et al.  Amlodipine potentiates metalloproteinase activity and accelerates elastin degradation in a model of aneurysmal disease. , 1998, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[7]  C. Quick,et al.  Epidemiology and potential for prevention of abdominal aortic aneurysm , 1998, The British journal of surgery.

[8]  J. Boyle,et al.  Doxycycline inhibits elastin degradation and reduces metalloproteinase activity in a model of aneurysmal disease. , 1998, Journal of vascular surgery.

[9]  B. Sonesson,et al.  The mechanical properties of elastic arteries in Ehlers-Danlos syndrome. , 1997, European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery.

[10]  W. Pearce,et al.  Expression of matrix metalloproteinases and their inhibitors in aneurysms and normal aorta. , 1997, Surgery.

[11]  C. Quick,et al.  Quality of the Measurement of the Infrarenal Aortic Diameter by Ultrasound , 1997, Journal of medical screening.

[12]  W. Pearce,et al.  Cellular Components and Features of Immune Response in Abdominal Aortic Aneurysms a , 1996, Annals of the New York Academy of Sciences.

[13]  A. Ghorpade,et al.  Biochemistry and Molecular Regulation of Matrix Macromolecules in Abdominal Aortic Aneurysms , 1996, Annals of the New York Academy of Sciences.

[14]  L. Klevay.  Trace Elements, Atherosclerosis, and Abdominal Aneurysms , 1996, Annals of the New York Academy of Sciences.

[15]  J. White,et al.  Formation and Growth of Aortic Aneurysms Induced by Adventitial Elastolysis , 1996, Annals of the New York Academy of Sciences.

[16]  P. Delvenne,et al.  Activated forms of MMP2 and MMP9 in abdominal aortic aneurysms. , 1996, Journal of vascular surgery.

[17]  R. Thompson,et al.  Indomethacin prevents elastase-induced abdominal aortic aneurysms in the rat. , 1996, The Journal of surgical research.

[18]  J. Powell,et al.  Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm. , 1995, Arteriosclerosis, thrombosis, and vascular biology.

[19]  T. Juvonen,et al.  Increased turnover of collagen in abdominal aortic aneurysms, demonstrated by measuring the concentration of the aminoterminal propeptide of type III procollagen in peripheral and aortal blood samples. , 1995, Journal of Vascular Surgery.

[20]  H A Ashton,et al.  Influence of screening on the incidence of ruptured abdominal aortic aneurysm: 5‐year results of a randomized controlled study , 1995, The British journal of surgery.

[21]  P. Dobrin,et al.  Failure of Elastin or Collagen as Possible Critical Connective Tissue Alterations Underlying Aneurysmal Dilatation , 1994, Cardiovascular surgery.

[22]  J. Powell,et al.  Pathogenesis of abdominal aortic aneurysm , 1994, The British journal of surgery.

[23]  M. R. Roach,et al.  The composition and mechanical properties of abdominal aortic aneurysms. , 1994, Journal of vascular surgery.

[24]  M. D. Tilson,et al.  Analysis of elastin cross-linking and the connective tissue matrix of abdominal aortic aneurysms. , 1994, Surgery.

[25]  C. Quick,et al.  An abdominal aortic aneurysm screening programme for all males over the age of 50 years. , 1994, European journal of vascular surgery.

[26]  N. Sakalihasan,et al.  Modifications of the extracellular matrix of aneurysmal abdominal aortas as a function of their size. , 1993, European journal of vascular surgery.

[27]  M. Tonelli,et al.  Content and turnover of extracellular matrix protein in human "nonspecific" and inflammatory abdominal aortic aneurysms. , 1993, European journal of vascular surgery.

[28]  D. Clayton,et al.  Statistical Models in Epidemiology , 1993 .

[29]  J. Powell,et al.  Mechanical properties of the aneurysmal aorta , 1993 .

[30]  W. Pearce,et al.  Enhanced production of the chemotactic cytokines interleukin-8 and monocyte chemoattractant protein-1 in human abdominal aortic aneurysms. , 1993, American Journal of Pathology.

[31]  A. Comerota,et al.  Adventitial elastolysis is a primary event in aneurysm formation. , 1993, Journal of vascular surgery.

[32]  N. Poulter,et al.  Abdominal aortic aneurysm: REPORT OF A MEETING OF PHYSICIANS AND SCIENTISTS, UNIVERSITY COLLEGE LONDON MEDICAL SCHOOL , 1993 .

[33]  D Bergqvist,et al.  Diameter and compliance in the male human abdominal aorta: influence of age and aortic aneurysm. , 1992, European journal of vascular surgery.

[34]  W. Marks,et al.  Decreased tissue inhibitor of metalloproteinases (TIMP) in abdominal aortic aneurysm tissue: a preliminary report. , 1991, The Journal of surgical research.

[35]  W. Pearce,et al.  Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. , 1990, The American journal of pathology.

[36]  P. Dobrin.  Mechanics of normal and diseased blood vessels , 1988, Annals of vascular surgery.

[37]  J. Risteli,et al.  Rapid equilibrium radioimmunoassay for the amino-terminal propeptide of human type III procollagen. , 1988, Clinical chemistry.

[38]  J. Powell,et al.  Elastin degradation in abdominal aortic aneurysms. , 1987, Atherosclerosis.

[39]  K. Kivirikko,et al.  [Biosynthesis of collagen and its disorders]. , 1979, Duodecim; laaketieteellinen aikakauskirja.

[40]  W. Pearce,et al.  Increased plasma levels of metalloproteinase-9 are associated with abdominal aortic aneurysms. , 1999, Journal of vascular surgery.

[41]  B. Baxter,et al.  Pathogenesis of aneurysms. , 1995, Seminars in vascular surgery.

[42]  F. Moll,et al.  Inflammation of the abdominal aortic aneurysm wall. , 1994, European journal of vascular surgery.